GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights

GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights

BackgroundRecently, a novel programmed cell death mechanism, Cuproptosis, has been discovered and found to play an important role in the development and progression of diverse tumors. In the present study, we comprehensively investigated the core gene of this mechanism, GLS, in breast cancer.Materia...

Full description

Bibliographic Details
Main Authors: Danfeng Zhang, Man Wang, Xufeng Huang, Longbin Wang, Ying Liu, Shujing Zhou, Yidan Tang, Qi Wang, Zhengrui Li, Geng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
breast cancer
bioinformatics
cuproptosis
biomarker
EMT pathway
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1220038/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1220038/full

Similar Items